COVID-19’s Endlessly Shifting Landscape
Experts from the Harvard Medical School-led Massachusetts Consortium on Pathogen Readiness, or MassCPR, respond to ongoing questions about the COVID-19 pandemic. Amy Barczak, assistant professor of
Menu
Does nerve damage contribute to ‘long-COVID’ symptoms?
During the COVID-19 pandemic, some people infected with the SARS-CoV-2 virus continue to experience “long-COVID” symptoms persisting at least three months after recovery from COVID,
COVID-19 survivors face increased mental health risks up to a year later
As the COVID-19 pandemic stretches into its third year, countless people have experienced varying degrees of uncertainty, isolation and mental health challenges. However, those who
Study identifies mutations specific to Omicron variant
While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that
Stop Using LuSys Laboratories COVID-19 Tests: FDA Safety Communication
Date Issued: January 11, 2022 The U.S. Food and Drug Administration (FDA) is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva)
Patient Receives Antibodies Discovered at Vanderbilt to Prevent COVID-19
Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from
Partners
 |
 |
 |
 |